Kinnari Patel - Net Worth and Insider Trading

Kinnari Patel Net Worth

The estimated net worth of Kinnari Patel is at least $9 Million dollars as of 2024-05-11. Kinnari Patel is the See Remarks of Rocket Pharmaceuticals Inc and owns about 378,903 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $9 Million. Details can be seen in Kinnari Patel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kinnari Patel has not made any transactions after 2024-02-16 and currently still holds the listed stock(s).

Transaction Summary of Kinnari Patel

To

Kinnari Patel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kinnari Patel owns 1 companies in total, including Rocket Pharmaceuticals Inc (RCKT) .

Click here to see the complete history of Kinnari Patel’s form 4 insider trades.

Insider Ownership Summary of Kinnari Patel

Ticker Comapny Transaction Date Type of Owner
RCKT Rocket Pharmaceuticals Inc 2024-02-16 Chief Operating Officer

Kinnari Patel Latest Holdings Summary

Kinnari Patel currently owns a total of 1 stock. Kinnari Patel owns 378,903 shares of Rocket Pharmaceuticals Inc (RCKT) as of February 16, 2024, with a value of $9 Million.

Latest Holdings of Kinnari Patel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RCKT Rocket Pharmaceuticals Inc 2024-02-16 378,903 22.72 8,608,676

Holding Weightings of Kinnari Patel


Kinnari Patel Form 4 Trading Tracker

According to the SEC Form 4 filings, Kinnari Patel has made a total of 4 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Rocket Pharmaceuticals Inc is the sale of 7,132 shares on February 16, 2024, which brought Kinnari Patel around $212,819.

Insider Trading History of Kinnari Patel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kinnari Patel Trading Performance

GuruFocus tracks the stock performance after each of Kinnari Patel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kinnari Patel is 58.57%. GuruFocus also compares Kinnari Patel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kinnari Patel within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kinnari Patel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kinnari Patel

Average Return

Average return per transaction

Outperforming Transactions

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 34.15
Relative Return to S&P 500(%) 27.25

Kinnari Patel Ownership Network

Ownership Network List of Kinnari Patel

No Data

Ownership Network Relation of Kinnari Patel


Kinnari Patel Owned Company Details

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Kinnari Patel is the Chief Operating Officer of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include See Remarks John Militello , director & See Remarks David P Southwell , and Chief Medical Officer Mark Andrew White .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Kinnari Patel made 2 insider transaction in Rocket Pharmaceuticals Inc (RCKT) with a net sale of 8,666. Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 23,282 shares made by John Militello , a net sale of 41,355 shares made by Gaurav Shah , and a net sale of 308,989 shares made by Gotham Makker .

In summary, during the past 3 months, insiders sold 418,173 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 418,173 shares. During the past 18 months, 486,057 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,057 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

Kinnari Patel Mailing Address

Above is the net worth, insider trading, and ownership report for Kinnari Patel. You might contact Kinnari Patel via mailing address: 430 East 29th Street, Suite 1040, New York Ny 10016.

Discussions on Kinnari Patel

No discussions yet.